Prediction of response to treatment with infliximab (Remicade®) in a German prospective open-label multicenter trial in refractory Crohn's disease
- 30 April 2001
- journal article
- abstracts
- Published by Elsevier in Gastroenterology
- Vol. 120 (5) , A621
- https://doi.org/10.1016/s0016-5085(08)83089-2
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: